Syndax Pharmaceuticals Inc (SNDX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -44.714 | -49.393 | -66.895 | -76.015 | -40.181 | 6.645 | -31.543 | -37.719 |
Return on Equity (%) | 52.856 | -64.526 | -93.999 | -132.425 | -51.558 | 7.547 | -34.103 | -40.985 |
Return on Invested Capital (%) | 51.391 | -67.072 | -98.752 | -136.622 | -47.59 | 7.523 | -34.128 | -46.702 |
Operating Margin (%) | -3645.246 | -2884.345 | -4875.478 | -3694.595 | -4667.172 | 19.201 | N/A | N/A |
Net Profit Margin (%) | -3645.246 | -2884.345 | -4875.478 | -3694.595 | -4822.544 | 17.841 | N/A | N/A |
Book Value Per Share | 4.407 | 4.129 | 2.136 | 1.164 | 5.267 | 7.427 | 6.863 | 7.958 |
Earnings Per Share | -2.329 | -2.406 | -2.978 | -2.065 | -1.528 | 0.453 | -2.193 | -3.006 |
Cash Per Share | 1.249 | 1.392 | 1.36 | 0.907 | 2.407 | 4.037 | 1.092 | 4.242 |
Working Capital Per Share | 5.141 | 4.656 | 2.707 | 1.62 | 5.848 | 7.779 | 6.764 | 7.507 |
Operating Profit Per Share | 0.064 | 0.083 | 0.061 | 0.056 | 0.032 | 2.541 | N/A | N/A |
EBIT Per Share | -2.329 | -2.406 | -2.978 | -2.065 | -1.528 | 0.453 | -2.193 | -3.006 |
EBITDA Per Share | -2.329 | -2.406 | -2.978 | -2.065 | -1.528 | 0.453 | -2.193 | -3.006 |
Free Cash Flow Per Share | -2.32 | -2.406 | -2.974 | -2.068 | -1.53 | 0.455 | -2.193 | -3.006 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 18,22M | 24,39M | 24,84M | 27,14M | 47,88M | 54,98M | 68,11M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 68,11M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 1,17B |
Ratio cours/bénéfice | -5,58 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 3,96 |
Ratio prix/valeur comptable | 2,11 |
Rendement de dividende | - |
Actions en circulation | 85,36M |
Volume moyen (1 semaine) | 2,51M |
Volume moyen (1 mois) | 3,05M |
Variation sur 52 semaines | -40,09% |
Plus haut sur 52 semaines | 25,34 |
Plus bas sur 52 semaines | 12,40 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales